TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH GLP-1 ANTAGONIST EXENDIN(9-39)

METHODS FOR EXTRACTING MELATONIN AND COMPOSITIONS THEREOF

BCMA CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

PHARMACEUTICAL COMPOSITION INJECTABLE INTO URINARY TRACT ORGAN CAVITY FOR PREVENTION OR TREATMENT OF UROTHELIAL CANCER

SAFE AND STABLE NIMODIPINE FORMULATION FOR INJECTION AND METHOD FOR PREPARING SAME

TRIPTOLIDE LIGNOCERATE, LIPOSOME THEREOF AND PREPARATION METHOD THEREFOR

MACROPHAGE-BASED THERAPY

LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN

INSULIN PREPARATIONS CONTAINING METHIONINE

LIQUID PHARMACEUTICAL COMPOSITION

Novel Parenteral Composition Comprising Linagliptin or its Salts

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION – UPREGULATION 1 (ACT-UP1) AND USES THEREOF

SIL-6R AND CTGF BINDING PROTEINS AND METHODS OF USE THEREOF

AZAINDOLE ROCK INHIBITORS

METHOD AND APPARATUS FOR SORTING HETEROGENEOUS MATERIAL

RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS

SARM1 RNAi AGENTS

COMBINATION THERAPY FOR TREATING TUMOR ANTIGEN EXPRESSING CANCERS

METHOD FOR TREATING HER2-POSITIVE SOLID TUMOR

NEUROTOXIN COMPOSITIONS FOR USE IN MODULATING STELLATE GANGLION ACTIVITY

METHODS OF TREATING CANCER

Formulations of Terlipressin

CANCER THERAPIES COMPRISING A NUCLEAR EXPORT INHIBITOR AND AN ONCOLYTIC VIRUS

TREATMENT OF BONE MARROW PATHOLOGIES WITH POLYSUFATED POLYSACCHARIDES

Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide

Aripiprazole Dosing Strategy

METHODS FOR TREATING NEUTROPENIA

STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND METHODS OF USE AND MANUFACTURE THEREOF

COMBINATION USES OF NITROXOLINE AND ITS ANALOGUES WITH CHEMOTHERAPIES AND IMMUNOTHERAPIES IN THE TREATMENT OF CANCERS

METHODS OF TREATING EPITHELIOID CELL TUMORS

COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID

MICROPARTICLES CONTAINING MOXIDECTIN AND SUSTAINED-RELEASE INJECTION COMPOSITION CONTAINING SAME

TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

METHOD AND SYSTEM FOR FACIAL AUGMENTATION

TREATMENT OF SOLID TUMORS

METHODS OF TREATING GASTROINTESTINAL INFLAMMATORY DISEASE

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

NOVEL CARBAMATE COMPOUND AND USE THEREOF

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

CORONAVIRUS VACCINE

ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN TROP2 AND USE THEREOF

Novel Stannic Protoporfin Compositions, Methods of Making, and Uses Thereof

Treatment Of Uterine Fibroids Using Purified Collagenase

MIXED PROTOCOL FOR TREATMENT OF INFERTILITY

HEPARIN-ASSOCIATED POLYPEPTIDES AND USES THEREOF

ADMINISTRATION OF AN ANTICANCER PEPTIDE

PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT

HUMAN PLATELET LYSATE DERIVED EXTRACELLULAR VESICLES FOR USE IN MEDICINE

INTRA-ERYTHROCYTE DEXAMETHASONE FOR TREATMENT OF ATAXIA-TELANGIECTASIA

BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS

IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM

DOXYCYCLINE INJECTION FOR SCLEROTHERAPY OF LOWER EYELID FESTOONS AND MALAR EDEMA

INJECTABLE FORMULATION

Topical Antifungal Non-Aqueous Formulations and Preparation Methods Thereof

CAPSAICIN SEQUENTIAL DOSING METHOD FOR TREATMENT OF KNEE JOINT PAIN

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

ENGINEERED CELLS AND USES THEREOF

TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRBeta ANTIBODY

Method of treating ulcerative colitis with an antibody to IL-23

DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR PREVENTION OF GUILLAN-BARRE SYNDROME BY THE USE OF THE ANTI-05 ANTIBODY CROVALIMAB

MULTIMERIC POLYPEPTIDES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

BETA-LACTAMASE INHIBITORS

MATERIALS AND METHODS FOR TREATMENT OF HEREDITARY HAEMOCHROMATOSIS

GENE THERAPY FOR AUTOSOMAL DOMINANT DISEASES

ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN THE CEREBELLUM AND A SECONDARY CELL TYPE

UTILIZATION OF NANOPARTICLES IN TARGETED THERAPY

COMPOSITION FOR ULTRASOUND ABLATION

SEMAGLUTIDE IN MEDICAL THERAPY

PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT

FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION

METHODS OF TREATING CANCER

PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF

COMBINATION THERAPY USING GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONIST COMPOUNDS AND GLP-1 RECEPTOR AGONIST COMPOUNDS

AQUEOUS TICAGRELOR SOLUTIONS, METHOD OF MANUFACTURING AND USES

HIGH DOSAGE INJECTABLE BEVACIZUMAB FORMULATIONS AND METHODS

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

HUMANIZED ANTIBODIES WITH INCREASED STABILITY

Production of Biosimilar Ustekinumab In CHO Cells

MALARIA VACCINE

PENTAAZA MACROCYCLIC RING COMPLEXES POSSESSING ORAL BIOAVAILABILITY

AAV CAPSID VARIANTS AND USES THEREOF

HYDROGEL PRODRUG FOR TREATMENT

HYDROGEL PRODRUG FOR TREATMENT

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

ENHANCED IMMUNE CELL THERAPY

CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM

TREATMENT OF ARGINASE 1 DEFICIENCY

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

FULVESTRANT FORMULATIONS

METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT

MORPHINE FORMULATIONS

BILASTINE COMPOSITION FOR ONCE-DAILY PARENTERAL ADMINISTRATION

LYOPHILIZED RESINIFERATOXIN

ETHANOLIC RESINIFERATOXIN CONCENTRATE

SYSTEMS AND METHODS FOR ACCELERATED HYDROLYSIS OF POLYSACCHARIDE-BASED HYDROGELS

PROTECTION OF BIOLOGICAL SPECIES FROM DEGRADATION

POLYNUCLEOTIDES ENCODING ANTIBODIES WHICH BIND THE EC3 DOMAIN OF CADHERIN-6 (CDH6) AND POSSESS INTERNALIZATION ABILITY

TREATING KNEE JOINT PAIN BY INJECTING RESINIFERATOXIN AT ULTRA LOW DOSES

TREATMENT OF DIABETES MELLITUS

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES

COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS

Hybrid Lipid Nanoparticle Comprising an Inorganic Particle and an Agent of Interest

MEDICAL AGENT INCLUDING ADJUVANT AND COMPOSITE OF PHOTOSENSITIVE MOLECULE AND MOLECULE BINDING TO CANCER-SPECIFIC CELL SURFACE MOLECULE

RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY

TREATMENT OF CONNECTIVE TISSUE INJURIES

COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER USING COMBINED THERAPY, COMPRISING LACTOBACILLUS PLANTARUM STRAIN AND ANTICANCER DRUG

CYTOKINE RECEPTOR AGONIST AND VIRAL VECTOR COMBINATION THERAPIES

COMPOSITION FOR LOCALIZED FAT REDUCTION WITHOUT PAIN, EDEMA AND SIDE EFFECTS AND METHOD OF ADMINISTRATION THEREOF

Oxabicycloheptanes for Modulation of Immune Response

FABP4 AS A THERAPEUTIC TARGET IN SKIN DISEASES

Pharmaceutical Combinations For The Treatment Of Cancer

POLYNUCLEOTIDES ENCODING FANCONI ANEMIA, COMPLEMENTATION GROUP PROTEINS FOR THE TREATMENT OF FANCONI ANEMIA

METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE

BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS

METHOD OF TREATING CHRONIC HEPATITIS B

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE

EMULSION FOR ULTRASOUND ABLATION SURGERY

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

METHOD OF TREATING A CANCER WITH A MULTIVALENT PEPTIDE CONJUGATE

IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER

MRNAS ENCODING CHECKPOINT CANCER VACCINES AND USES THEREOF

PEPTIDES AND METHODS FOR USE IN TREATING PAIN

COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING INTESTINAL INFLAMMATION

FORMULATION FOR ADMINISTRATION OF RNA

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROGENERATIVE DISEASE

METHODS OF TREATMENT

BUPRENORPHINE DOSING REGIMENS

A PREMIXED ROOM TEMPERATURE STABLE COMPOSITION OF FAMOTIDINE FOR INTRAVENOUS BOLUS INJECTION AND METHOD THEREOF

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF COGNITIVE DYSFUNCTION

5-MEO-DMT FOR USE IN THE TREATMENT OF NEGATIVE THINKING

5-METHOXY-N.N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF PSYCHOMOTOR RETARDATION

METHOD FOR PREPARING MICROPARTICLES CONTAINING MOXIDECTIN AND SUSTAINED RELEASE INJECTABLE COMPOSITION COMPRISING MICROPARTICLES PREPARED BY SAME PREPARATION METHOD

METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS

CONTINUOUS ADMINISTRATION OF PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL HYDROCHLORIDE FOR THE TREATMENT OF PEDIATRIC PATIENTS

PHARMACEUTICAL COMPOSITION COMPRISING BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION AND PROCESS OF PREPARING THEREOF

Ionic Liquid-Incorporated Lipid Nanoparticles

Method of Treating Osteoarthritis

Intra-Incisional Injection of Antibiotics and Other Injections Into Skin and Mucosa

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

PORTABLE DRUG MIXING AND DELIVERY DEVICE AND ASSOCIATED METHODS

DENDRIMER COMPOSITIONS AND USE IN TREATMENT OF NEUROLOGICAL AND CNS DISORDERS

METHODS AND COMPOSITIONS FOR TREATING RBM20 RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR

TREATMENT REGIMENS FOR THERAPEUTIC EFFECTOR COMPONENTS THAT ACT VIA AN INTRACELLULAR MOLECULAR TARGET

Antibody Compositions and Methods of Use Thereof

COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME

FORMULATION COMPRISING OZONISED OIL IN THE TREATMENT OF A TUMOUR

THERAPEUTIC COMPOUND AND SALTS

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

PHENYLEPHRINE HYDROCHLORIDE READY-TO-USE SOLUTION

SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES

Octreotide Depot Formulation with Constantly High Exposure Levels

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES

HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS

STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES

IMMUNOREGULATORY AMIDE DERIVATIVE WITH IMPROVED MATERIAL PROPERTIES

Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies

DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS

COVALENT ANESTHETIC-POLYMER CONJUGATES FOR PROLONGED LOCAL ANESTHESIA

PROCESS FOR PRODUCING POLYMER-STABILIZED ANTIOXIDANT CRYSTALS

High Concentration Bispecific Antibody Formulations

THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER

METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY

SYNTHETIC PLATELETS

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

METHODS FOR REGULATING FREE FATTY ACID FLUX USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS

Compositions and Methods for Treating Neuropathy

METHODS AND COMPOSITIONS FOR CANCER THERAPY

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

Use of Genipin-1-B-D-Gentiobioside in Preparation of Drug

PSYCHEDELIC DRUG TREATMENT OF NEUROPSYCHIATRIC DISORDERS AND CEREBRAL PALSY

COMPOUNDS AND COMPOSITIONS FOR ANITMALARIAL THERAPEUTIC AND PROPHYLACTIC USE

INJECTABLE PREPARATION COMPRISING ISOXAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR

Piezo Inhibition for Wound Healing

Polymer Nanoaggregate Pharmaceutical Composition and Use Thereof

LIQUID FORMULATIONS OF GLUCAGON ANALOGUES

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS

PHARMACEUTICAL FORMULATIONS OF R-KETAMINE

NOVEL IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING LYMPHOCYTES DERIVED FROM VECTOR TRANSDUCED HSCS FOR THERAPY OF DISORDERS

COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES

IN UTERO TREATMENT OF A FETUS HAVING GENETIC DISEASE/NEUROMUSCULAR DISEASE

TRIPLE COMBINATION DRUG DOSING THERAPY FOR HEAD AND NECK CANCER TREATMENT

METHODS OF TREATING AL AMYLOIDOSIS

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

VIRAL VECTORS ENCODING GLP-2 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING SHORT BOWEL SYNDROME

VIRAL VECTORS ENCODING PARATHYROID HORMONE FUSIONS AND USES THEREOF IN TREATING HYPOPARATHYROIDISM

METHODS FOR DETECTING AND REVERSING IMMUNE THERAPY RESISTANCE

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

Zonal and Targeted Methods and Uses for Treating a Post-Traumatic Stress Disorder

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

PHARMACEUTICAL COMPOSITION OF IL2 MUTANT-ANTIBODY FC BLOCK FUSION PROTEIN AND USE THEREOF

GIP/GLP1 AGONIST COMPOSITIONS

SUSTAINED RELEASE PEPTIDE FORMULATIONS

HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE

POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USE THEREOF IN TREATING COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP)

ABIRATERONE DECANOATE PRODRUGS AND USE IN THERAPY

NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS

METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY ASSOCIATED WITH AUTISM SPECTRUM DISORDER, RETT SYNDROME, AND FRAGILE X SYNDROME

METHODS OF TREATING INFLAMMATORY AND/OR ALLERGIC DISORDERS WITH NORKETOTIFEN

EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS

FORMULATIONS OF BENDAMUSTINE

USE OF AMISULPRIDE AS AN ANTI-EMETIC

Taxane Particles and Their Use

Method of Preventing and Treating Chemotherapy- Induced Alopecia

PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION

NOREPINEPHRINE COMPOSITIONS AND METHODS THEREFOR

PHARMACOLOGICAL PROPHYLACTICS AGAINST STRESS-INDUCED AFFECTIVE DISORDERS IN FEMALES

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

ANTIEMETIC COMBINATIONS

THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER

RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY

COMPOUNDS AND METHODS FOR MODULATING SMN2

Modified Bont/A for Use in the Treatment of a Disorder Affecting an Eyelid Muscle of a Subject

Integrin Alpha10 Antibody

USE OF TGF-ALPHA POLYPEPTIDE OR ANTI-TGF-ALPHA ANTIBODIES FOR THE TREATMENT OF DISEASES AND DISORDERS

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

USE OF FCRN ANTAGONISTS FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS

NOVEL DIPEPTIDE COMPOUNDS AND USES THEREOF

COMPOSITION FOR USE IN THE TREATMENT OF FABRY DISEASE

FUNCTIONALIZED NANOPARTICLES FOR THE CONTAINMENT AND CLEARANCE OF PATHOGENS

STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF AS IMMUNO-THERAPEUTIC AGENTS AGAINST SOLID TUMORS

mRNA VACCINE

PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL

METHODS FOR ADMINISTERING FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS TO SUBJECTS TREATED WITH A FACTOR XI INHIBITOR

METHODS AND COMPOSITIONS FOR TREATING STROKE

RNA MOLECULES AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY

PHOTORESPONSIVE PEPTIDE DELIVERY SYSTEM AND METHOD OF USING THE SAME

METHODS OF TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS

METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE

FORMULATIONS OF BENDAMUSTINE

THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES

METHOCARBAMOL COMPOSITIONS AND RELATED METHODS

TRANEXAMIC ACID FORMULATION AND INTRAMUSCULAR INJECTION METHOD

NOREPINEPHRINE COMPOSITIONS AND METHODS THEREFOR

CMT-3 FORMULATIONS AND METHODS OF USING THE SAME

A DRUG NANOCARRIER SYSTEM TO DELIVER A COMBINATION OF TLR AGONISTS AND/OR A LIPOXIN PLUS IMMUNOGENIC CELL DEATH INDUCING CHEMOTHERAPEUTIC AGENTS FOR CANCER IMMUNOTHERAPY

SLURRY AND SOLUTION COMPOSITIONS

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

METHODS AND SYSTEMS FOR INJECTABLE FORMULATIONS

METHODS AND COMPOSITIONS FOR CAR T CELL THERAPY

APTAMERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR PREVENTING OR TREATING BCMA-ASSOCIATED DISEASES OR CONDITIONS

ANTISENSE OLIGOMERS AND METHODS OF USING THE SAME FOR TREATING DISEASES ASSOCIATED WITH THE ACID ALPHA-GLUCOSIDASE GENE

METHODS OF PREPARING HIGH CONCENTRATION LIQUID DRUG SUBSTANCES

Bispecific Constructs for Target and Complement Engagement

METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS

TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND

COMPOSITIONS AND METHODS FOR DEPLETION OF DISEASED HEMATOPOIETIC STEM CELLS

ANTI-TNF ALPHA ANTIBODY FORMULATIONS

STABLE, AQUEOUS FORMULATIONS OF ANTIBODIES THAT BIND IL5 RECEPTOR

COLLOIDAL PARTICLES FOR USE IN MEDICINE

C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA IN CHILDREN

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

Methods of Treating Alzheimer's Disease

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONS

TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION

METHOD FOR THE TREATMENT OF ANTERIOR ISCHEMIC OPTIC NEUROPATHY

TREATMENT OF POSTNATAL DEPRESSION

IMMUNOREGULATORY MICROPARTICLES FOR MODULATING INFLAMMATORY ARTHRITIDES

POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE

NANOPREPARATION FOR JOINT ANALGESIA, AND PREPARATION METHOD AND USE THEREOF

Carrier-Binding Agent Compositions and Methods of Making and Using the Same

Treatment of Pneumonia

EPHEDRINE LIQUID FORMULATIONS

ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

ANTIBODY FORMULATION

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

CHIMERIC NEUROTROPIC AAV CAPSIDS

CONJUGATES OF PHENYLALANINE AMMONIA-LYASE AND POEGMA AND METHODS FOR THEIR USE

COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT

COMPOSITIONS AND METHODS FOR TREATMENT OF PSORIASIS

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

METHODS FOR DECREASING PATHOLOGIC ALPHA-SYNUCLEIN USING AGENTS THAT MODULATE FNDC5 OR BIOLOGICALLY ACTIVE FRAGMENTS THEREOF